期刊文献+

硫氧还蛋白还原酶活性检测试剂盒在恶性肿瘤辅助诊断中的价值 被引量:11

Clinical value of Thioredoxin Reductase Detection Kit for diagnosis of cancers
下载PDF
导出
摘要 目的探讨硫氧还蛋白还原酶(TR)活性检测试剂盒在恶性肿瘤辅助诊断中的价值。方法检测不同地区、不同检验机构1122例健康人群TR活性,差异有无统计学意义;检测84例恶性肿瘤患者TR活性,并与健康人群比较,差异有无统计学意义,通过ROC曲线对检测结果进行分析评价。结果北京体检机构的TR活性均值为(2.6±4.1)U/mL,武汉体检机构的TR均值为(2.6±3.7)U/mL,湖北中医药大学附属医院的TR均值为(2.4±3.5)U/mL,各组间TR活性水平差异无统计学意义(P>0.05);肿瘤组TR活性均值为(9.2±6.4)U/mL,健康组TR活性为(2.5±3.7)U/mL,两者间差异有统计学意义(P<0.05)。固定健康组和肿瘤组的样本比例为4:1,不同的样本量间TR活性差异无统计学意义(P>0.05)。ROC曲线下面积为0.812±0.029。结论组间均数比较U检验和ROC曲线评价均显示,TR活性检测试剂盒用于与异常增生密切相关的肿瘤生长的临床血样检测具有重要的实用价值。 Objective To evaluate the clinical value of Thioredoxin Reductase(TR) Detection Kit for diagnosis of cancers.Methods Serum levels of TR were detected by TR Detection Kit in 1 122 healthy subjects from different regions and medical institutions and 84 patients with different cancers.Differences of the detected results between each group were compared and ROC curve was prepared to evaluate the specificity and sensitivity of this detection.Results Serum levels of TR in the three healthy subgroups were(2.6±4.1),(2.6±3.7) and(2.4±3.5)U/mL,with no statistical difference between the three subgroups(P〉0.05),and the difference was barely significant between 3 samples with fixed ratio(P〈0.05).Serum levels of TR in cancer group was(9.2±6.4)U/mL,with statistical difference with the(2.5±3.7)U/mL in healthy group(P〈0.05).There was no statistical difference between The area under ROC curve was 0.812±0.029.Conclusion Detection of TR by TR Detection Kit could be valuable for clinical diagnosis of cancers.
出处 《国际检验医学杂志》 CAS 2012年第13期1580-1581,1583,共3页 International Journal of Laboratory Medicine
关键词 肿瘤标志物 硫氧还蛋白还原酶 试剂盒 诊断 tumor marker; thioredoxin reductase; reagent kits,diagnostic
  • 相关文献

参考文献10

  • 1Rene B. Finding biomarkers of resistance to targeted cancer ther- apies[J]. European Journal of Cancer Supplements, 2007,5 (5) 109 114.
  • 2谢跃文,王强,夏洁.肿瘤标志物检测在恶性肿瘤诊断中的应用[J].国际检验医学杂志,2011,32(1):107-109. 被引量:28
  • 3Nguyen P, Awwad RT, Smart DD, et al. Thioredoxin reductase as a novel molecular target for cancer therapy[J]. Cancer Letters, 2006,236(2) :164-174.
  • 4Sabine U, Katja B. On the potential of thioredoxin reductase in- hibitors for cancer therapy[J]. Seminars in Cancer Biology, 2006, 16(6):452-465.
  • 5Powis G, Kirkpatrick DL. Thioredoxin signaling as a target for cancer therapy[J]. Curt Open Pharmaeol. 2007,7 (4) : 392-397.
  • 6Cristine S, Maria J, Paolo P, el al. Statins inhibit expression of Thioredoxin reductase 1 in rat and human liver and reduce tumor development[J]. Biochemical and Biophysical Research Communi- cations,2012,417(3):1046-1051.
  • 7罗疏薇,欧春萍,张莉萍,陈宏础.应用ROC曲线评价CEA、CYFRA21-1、SCC对非小细胞肺癌的诊断价值[J].重庆医学,2011,40(3):250-252. 被引量:43
  • 8陈卫中,倪宗瓒,潘晓平,刘元元,夏彦.用ROC曲线确定最佳临界点和可疑值范围[J].现代预防医学,2005,32(7):729-731. 被引量:208
  • 9Kim HJ,Chae HZ, Kim YJ, et al. Preferential elevationof Prx L and Trx expression in lung cancer cells follow-ing hypoxia and in human lung cancer tissues[J]. Cell Biol Toxicol, 2003,19 (5) : 285-298.
  • 10江梅,崔艳丽,何利珍.多肿瘤标志物在肺癌诊断检测中的价值[J].国际检验医学杂志,2010,31(12):1458-1459. 被引量:12

二级参考文献31

共引文献283

同被引文献67

  • 1孙华启.33例肺结核合并肺癌原因分析[J].华西医学,2009,24(12):3183-3184. 被引量:1
  • 2宋萍,王学美,谢爽,卜定方.鲜壁虎冻干粉抑制H22肿瘤血管生成机理的实验研究[J].中国中西医结合杂志,2006,26(1):58-62. 被引量:48
  • 3郑苇.肺癌和肺结核的病例对照研究.中华结核和呼吸杂志,1988,11(3):135-135.
  • 4Noe DA, Weedn V, Bell WR. Direct spectrophotome- tery of serum hemoglobin: an Allan correction com- pared with a three-wavelength polychromatic analysis [ J]. Clin Chem, 1984,30(5 ) :627-630.
  • 5Holmgren A. Redox regulation by thioredoxin and thioredoxin reductase [ J ]. Biofactors, 2000,11 ( 1/2 ) : 63 -64.
  • 6Tonissen KF, Di Trapani G. Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy[ J]. Mol Nutr Food Res,2009,53 ( 1 ) :87 - 103.
  • 7Soderberg A, Sahaf B, Rosen A. Thioredoxin reductase, a redoxactive selenoprotein, is secreted by normal and neoplastic cells:presence in human plasma [ J ]. Cancer Res,2000,60(8) :2281 - 2289.
  • 8Fernandes AP, Capitanio A, Selenius M, et al. Expression profilesof thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differen- tiation [ J ]. Histopathology ,2009,55 ( 3 ) : 313 - 320.
  • 9Zhao F, Yan J, Deng L, et al. A thioredox in reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines [ J ]. Cancer Lett, 2006,236( 1 ) :46 - 53.
  • 10Lincoln DT, All Emadi EM, Tonissen KF, et al. The thioredoxin-thioredoxin reductase system: over-expression in human cancer [ J ]. Anticancer Res, 2003,23 ( 3B ) : 2425 - 2433.

引证文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部